Skip to main content

Table 1 Clinical characteristics regarding 18 patients of 36 CMLNs treated with implantation of 125I-seeds

From: Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma

Parameter Characteristics Result
Sex of patients (n = 18) M/F 11/7A
Age of patients (n = 18)   52.2 ± 20.8 (27–87) B
Subtypes of DTC (n = 18) PTC/FTC 17/1 (94/6) C
No. of neck surgeries performed (n = 18) < 3/≥3 16/2 (89/11) C
Cumulative dose of RAI-131 (n = 18) < 600/≥600mci 14/4 (78/22) C
BRAFV600E mutation (n = 18) P/N 17/1 (94/6) C
No. of CMLNs (n = 18) 1 9 (50) C
2 3 (17) C
≥3 6 (33) C
Sides of CMLNs (n = 36) L/R 15/21 (42/58) D
Level of CMLNs (n = 36) I 0 (0) D
II 6 (17) D
III 12 (33) D
IV 10 (28) D
V 1 (3) D
VI 7 (19) D
Largest diameter of CMLNs (n = 36) (mm)   14.0 (8.0, 22.5) E
Initial volume of nodule (n = 36) (mm3)   523 (148, 2010) E
  1. M male, F female, PTC papillary thyroid carcinoma, FTC follicular thyroid carcinoma, P positive, N negative, L left, R right
  2. A Number of patients
  3. B Mean ± standard deviation, with range in brackets
  4. C Number of patients, with percentage in brackets
  5. D Number of CMLNs, with percentage in brackets
  6. E Median, with P25 and P75 in brackets